| | UNITED
                                       STATESSECURITIES AND
                                       EXCHANGE COMMISSIONWashington, D.C. 20549
        
        FORM
        10-Q/A | 
| | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- | 
| |                                                                                                                                                                                         
| |                                                                                                                                                                                         
| |                                                                                                                                                                                         
| |                                                                                                                                                                                         
| |                                                                                                                                                                                         
|



(Mark
One)



☒
 QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934



For
the quarterly period ended: March 31, 2020



☐
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
ACT OF 1934



|For
    the transition period from | to
|---------------------------------- | --



Commission
File Number: 0-30746



TRICCAR,
INC.

(Exact
name of registrant as specified in its charter)



|Nevada                                                             | 84-4250492                              
|------------------------------------------------------------------ | ----------------------------------------
|(State
    or other jurisdiction of incorporation or organization) | (I.R.S.
    Employer Identification No.)
|                                                                   |                                         
|848
    N. Rainbow Blvd., #3254, Las Vegas, Nevada                 | 89107                                   
|(Address
    of principal executive offices)                       | (Zip Code)                              



702-330-2430

(Registrant’s
telephone number, including area code)



Frontier
Oilfield Services, Inc., 220 Travis Street, Suite 501, Shreveport, Louisiana 71101

(Former
name, former address and former fiscal year, if changed since last report)



Securities
registered pursuant to Section 12(b) of the Act:

|Title
    of each class                       | Trading
    
Symbol(s) | Name
    of each exchange on which registered
|--------------------------------------------- | ---------------------- | ---------------------------------------------
|Common
    Stock, $0.0001 par value per share | FOSI                   |                                              





Indicate
by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities
Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such
reports), and (2) has been subject to such filing requirements for the past 90 days.

Yes      ☐    No     ☒



Indicate
by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant
to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that
the registrant was required to submit such files).

Yes      ☐    No        ☒



Potential
persons who are to respond to the collection of information contained in this form are not required to respond
unless the form displays a currently valid OMB control number.



Indicate
by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting
company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,”
“smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.



|Large
    accelerated filer | ☐ |  |                               |   | 
|--------------------------- | - |  | ----------------------------- | - | 
|Accelerated
    filer       | ☐ |  | Smaller
    reporting company | ☒ | 
|Non-accelerated filer       | ☐ |  | Emerging
    growth company   | ☒ | 



If
an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period
for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐



Indicate
by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes  ☐     No   ☒



APPLICABLE
ONLY TO CORPORATE ISSUERS:



Indicate
the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

As
of July 21, 2020 there were 72,500,000 shares of Class A common stock and 27,500,000 shares of Class B common stock outstanding
pending issuance with name and symbol change.






















EXPLANATORY NOTE



TRICCAR, Inc. formerly known as Frontier Oilfield
Services, Inc. a Nevada corporation (and collectively with its subsidiaries, “we”, “our”, “TRICCAR”,
“Frontier”, “FOSI”, or the “Company”) is filing this Amendment No. 1 on Form 10-Q/A (this “Amendment”)
to amend its Quarterly Report on Form 10-Q for the quarter ended March 31, 2020, originally filed with the U.S. Securities and
Exchange Commission (the “Commission”) on July 10, 2020 (the “Original 10-Q”). The purpose of this Amendment
is to add this additional disclosure of the Company’s reliance on the March 4, 2020 order issued by the Commission under
Section 36 (Release No. 34-88318), as modified on March 25, 2020 (Release No. 34-88465) of the Securities Exchange Act of 1934
(“Exchange Act”) granting exemptions from specified provisions of the Exchange Act and certain rules thereunder (the
“Order”), as a result of the novel coronavirus (“COVID-19”) pandemic, to file the Company’s Original
10-Q when originally due on May 15, 2020.



The Company was not able to file its Original
10-Q by the original due date as a result of disruptions caused by the COVID-19 pandemic. The COVID-19 pandemic has impacted the
Company through inaccessibility to key partners and their services. A significant portion of the Company’s business operations
are contracted in certain domestic markets currently on “lock-down” orders or “shelter in place” recommendations
for the national health crisis, including key personnel responsible for assisting the Company in the development of its financial
statements. As a result of the travel and work restrictions stemming from the COVID-19 pandemic, the Company was unable to obtain
financial records that it needs from its operations to permit the Company to file a timely and accurate Quarterly Report on Form
10-Q for its quarter ended March 31, 2020 by the prescribed date without undue hardship and expense to the Company.



This Amendment does not amend or otherwise
update any other information in the Original 10-Q. Accordingly, this Amendment should be read in conjunction with the Original
10-Q.













TRICCAR,
INC.Index



|                               |                                                                                                                            | Pg.
    No.
|------------------------------ | -------------------------------------------------------------------------------------------------------------------------- | -----------
|PART I — Financial Information |                                                                                                                            |            
|Item 1.                        | Financial Statements                                                                                                       |            
|                               | Consolidated Balance Sheets as of March 31, 2020 and December 31, 2019 (Unaudited)                                         |            
|                               | Consolidated Statements of Operations for the Three Months Ended March 31, 2020 and 2019 (Unaudited)                       |            
|                               | Consolidated Statements of Cash Flows for the Three Months Ended March 31, 2020 and 2019 (Unaudited)                       |            
|                               | Consolidated Statements of Changes in Stockholders’ Deficit for the Three Months Ended March 31, 2020 and 2019 (Unaudited) |            
|                               | Notes to Consolidated Financial Statements as of March 31, 2020 (Unaudited)                                                |            
|Item 2.                        | Management’s Discussion and Analysis of Financial Condition and Results of Operations                                      |            
|Item 3.                        | Quantitative and Qualitative Disclosures about Market Risk                                                                 |            
|Item 4.                        | Controls and Procedures                                                                                                    |            
|                               |                                                                                                                            |            
|PART II — Other Information    |                                                                                                                            |            
|Item 1.                        | Legal Proceedings                                                                                                          |            
|Item 2.                        | Unregistered Sales of Equity Securities and Use of Proceeds                                                                |            
|Item 3.                        | Defaults Upon Senior Securities                                                                                            |            
|Item 5.                        | Other Information                                                                                                          |            
|Item 6.                        | Exhibits                                                                                                                   |            
|                               |                                                                                                                            |            
|SIGNATURES                     |                                                                                                                            | 13         











PART
1 — FINANCIAL INFORMATION



ITEM
1. FINANCIAL STATEMENTS



TRICCAR,
INC. AND SUBSIDIARIES

CONSOLIDATED
BALANCE SHEETS

(UNAUDITED)



|                                                                                                                                          |  |                |          |   |                   |  
|----------------------------------------------------------------------------------------------------------------------------------------- |  | -------------- | -------- | - | ----------------- | -
|                                                                                                                                          |  | March 31, 2020 |          |   | December 31, 2019 |  
|                                                                                                                                          |  |                |          |   |                   |  
|ASSETS                                                                                                                                    |  |                |          |   |                   |  
|Current Assets:                                                                                                                           |  |                |          |   |                   |  
|Cash                                                                                                                                      |  | $              | 20,261   |   |                   | $
|Total current assets                                                                                                                      |  |                | 20,261   |   |                   |  
|                                                                                                                                          |  |                |          |   |                   |  
|Total Assets                                                                                                                              |  | $              | 20,261   |   |                   | $
|                                                                                                                                          |  |                |          |   |                   |  
|LIABILITIES AND STOCKHOLDERS’ DEFICIT                                                                                                     |  |                |          |   |                   |  
|Current Liabilities:                                                                                                                      |  |                |          |   |                   |  
|Accounts payable                                                                                                                          |  | $              | 168,411  |   |                   | $
|Accrued liabilities                                                                                                                       |  |                | 48,830   |   |                   |  
|Total current liabilities                                                                                                                 |  |                | 217,241  |   |                   |  
|                                                                                                                                          |  |                |          |   |                   |  
|Total Liabilities                                                                                                                         |  |                | 217,241  |   |                   |  
|Commitments and Contingencies (Note 5)                                                                                                    |  |                |          |   |                   |  
|Stockholders’ Equity (Deficit):                                                                                                           |  |                |          |   |                   |  
|Preferred stock $.0001 par value; authorized 50,000,000 shares with no outstanding as March 31, 2020 and December 31, 2019                |  |                | —        |   |                   |  
|Common stock- Class A $.00001 par value; authorized 100,000,000 shares with 52,500,000 shares issued and outstanding at December 31, 2019 |  |                | —        |   |                   |  
|Common stock- Class B $.00001 par value; authorized 30,000,000 shares with 27,500,000 shares issued and outstanding at December 31, 2019  |  |                | —        |   |                   |  
|Common stock- Class A $.0001 par value; authorized 372,500,000 shares with 72,500,000 shares issued and outstanding at March 31, 2020     |  |                | 7,250    |   |                   |  
|Common stock- Class B $.0001 par value; authorized 27,500,000 shares with 27,500,000 shares issued and outstanding at March 31, 2020      |  |                | 2,750    |   |                   |  
|Additional paid-in capital                                                                                                                |  |                | —        |   |                   |  
|Accumulated deficit                                                                                                                       |  |                | (206,980 | ) |                   |  
|Total stockholders’ equity (deficit)                                                                                                      |  |                | (196,980 | ) |                   |  
|Total Liabilities and Stockholders’ Equity (Deficit)                                                                                      |  | $              | 20,261   |   |                   | $



The
accompanying notes are an integral part of these consolidated financial statements.





3







TRICCAR,
INC. AND SUBSIDIARIES



CONSOLIDATED
STATEMENTS OF OPERATIONS

(UNAUDITED)



|                                            |  | For the Three Months Ended |           
|------------------------------------------- |  | -------------------------- | ----------
|                                            |  | March 31, 2020             |           
|                                            |  |                            |           
|Revenue, net of discounts                   |  | $                          | —         
|Costs and expenses:                         |  |                            |           
|General and administrative                  |  |                            | 27,620    
|Total costs and expenses                    |  |                            | 27,620    
|Operating loss                              |  |                            | (27,620   
|Other (income) expense:                     |  |                            |           
|Interest expense                            |  |                            | —         
|Loss before provision for income taxes      |  |                            | (27,620   
|Provision for income taxes                  |  |                            | —         
|Net loss                                    |  | $                          | (27,620   
|                                            |  |                            |           
|Net loss per common share – basic:          |  | $                          | (0.00     
|                                            |  |                            |           
|Weighted Average Common Shares Outstanding: |  |                            |           
|Basic                                       |  |                            | 86,666,667



The
accompanying notes are an integral part of these consolidated financial statements.



4







TRICCAR,
INC. AND SUBSIDIARIES

CONSOLIDATED
STATEMENTS OF CASH FLOWS

(UNAUDITED)



|                                                                            |  |                            |         |   |                |  
|--------------------------------------------------------------------------- |  | -------------------------- | ------- | - | -------------- | -
|                                                                            |  | For the Three Months Ended |        
|                                                                            |  | March 31, 2020             |         |   | March 31, 2019 |  
|Cash Flows from Operating Activities:                                       |  |                            |         |   |                |  
|Net loss                                                                    |  | $                          | (27,620 | ) |                | $
|Adjustments to reconcile net loss to net cash used in operating activities: |  |                            |         |   |                |  
|Depreciation and amortization                                               |  |                            | —       |   |                |  
|                                                                            |  |                            |         |   |                |  
|Changes in operating assets and liabilities:                                |  |                            |         |   |                |  
|(Increase) decrease in operating assets:                                    |  |                            |         |   |                |  
|Accounts receivable                                                         |  |                            | —       |   |                |  
|Increase (decrease) in operating liabilities:                               |  |                            |         |   |                |  
|Accounts payable                                                            |  |                            | —       |   |                |  
|Accrued liabilities                                                         |  |                            | 16,339  |   |                |  
|Net cash used in operating activities                                       |  |                            | (11,281 | ) |                |  
|                                                                            |  |                            |         |   |                |  
|Cash Flows from Investing Activities                                        |  |                            | —       |   |                |  
|                                                                            |  |                            |         |   |                |  
|Cash Flows from Financing Activities:                                       |  |                            |         |   |                |  
|Proceed from equity investment                                              |  |                            | 2,075   |   |                |  
|                                                                            |  |                            |         |   |                |  
|Net cash provided from financing activities:                                |  |                            | 2,075   |   |                |  
|                                                                            |  |                            |         |   |                |  
|Net decrease in cash                                                        |  |                            | (9,206  | ) |                |  
|Cash at beginning of the period                                             |  |                            | 29,467  |   |                |  
|Cash at end of the period                                                   |  | $                          | 20,261  |   |                | $
|                                                                            |  |                            |         |   |                |  
|Supplemental Cash Flow Disclosures                                          |  |                            |         |   |                |  
|Cash paid for:                                                              |  |                            |         |   |                |  
|Interest                                                                    |  | $                          | —       |   |                | $
|Taxes                                                                       |  | $                          | —       |   |                | $
|Supplemental Disclosure of Non-Cash Investing and Financing                 |  |                            |         |   |                |  
|Accounts payable acquired in reverse merger                                 |  | $                          | 168,411 |   |                | $



The
accompanying notes are an integral part of these consolidated financial statements.



5







TRICCAR,
INC. AND SUBSIDIARIESCONSOLIDATED STATEMENT OF CHANGES IN STOCKHOLDERS’
EQUITY

FOR
THE THREE MONTHS ENDED MARCH 31, 2020

(UNAUDITED)



|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  | Additional    |       |   |         |   |          | Total            | 
|----------------------------------------------------------- |  | -------------------- | ----------- | - | -------------------- | - | ----- | ------- |  |  | ----------- | - |  | ------------- | ----- | - | ------- | - | -------- | ---------------- | 
|                                                            |  | Common Stock Class A |             |   | Common Stock Class B |   |       | Paid-In |  |  | Accumulated |   |  | Stockholders’ |      
|                                                            |  | Shares               |             |   | Par Value            |   |       | Shares  |  |  | Par Value   |   |  | Capital       |       |   | Deficit |   |          | Equity (Deficit) | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Balance December31, 2018 of TRICCAR Holdings, Inc.          |  |                      | 52,376,527  |   |                      | $ | 524   |         |  |  | 27,500,000  |   |  | $             | 275   |   |         | $ | 23,402   |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Net Loss                                                    |  |                      | —           |   |                      |   | —     |         |  |  | —           |   |  |               | —     |   |         |   | —        |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Balance March 31, 2019 of TRICCAR Holdings, Inc.            |  |                      | 52,376,527  |   |                      | $ | 524   |         |  |  | 27,500,000  |   |  | $             | 275   |   |         | $ | 23,402   |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Balance December31, 2019 of TRICCAR Holdings, Inc.          |  |                      | 52,500,000  |   |                      | $ | 525   |         |  |  | 27,500,000  |   |  | $             | 275   |   |         | $ | 101,401  |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Additional paid in capital                                  |  |                      | —           |   |                      |   | —     |         |  |  | —           |   |  |               | —     |   |         |   | 2,075    |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Recapitalization on reverse merger - purging previous share |  |                      | (52,500,000 | ) |                      |   | (525  | )       |  |  | (27,500,000 | ) |  |               | (275  | ) |         |   | (103,476 | )                | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Recapitalization on reverse merger - issuance of new share  |  |                      | 72,500,000  |   |                      |   | 7,250 |         |  |  | 27,500,000  |   |  |               | 2,750 |   |         |   | —        |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Net Loss                                                    |  |                      | —           |   |                      |   | —     |         |  |  | —           |   |  |               | —     |   |         |   | —        |                  | 
|                                                            |  |                      |             |   |                      |   |       |         |  |  |             |   |  |               |       |   |         |   |          |                  | 
|Balance March 31, 2020                                      |  |                      | 72,500,000  |   |                      | $ | 7,250 |         |  |  | 27,500,000  |   |  | $             | 2,750 |   |         | $ | —        |                  | 



The
accompanying notes are an integral part of these consolidated financial statements.





6







TRICCAR,
INC. AND SUBSIDIARIES

NOTES
TO CONSOLIDATED FINANCIAL STATEMENTS

March
31, 2020

(UNAUDITED)



|1. | BASIS
    OF PRESENTATION
|-- | -------------------------



The
consolidated financial statements included herein have been prepared by TRICCAR, Inc. (“the Company”), without audit,
pursuant to the rules and regulations of the Securities and Exchange Commission. Certain information and footnote disclosures
normally included in financial statements prepared in accordance with U.S. generally accepted accounting principles have been
omitted. However, in the opinion of management, all adjustments (which include only normal recurring adjustments, unless otherwise
indicated) necessary to present fairly the financial position and results of operations for the periods presented have been made.
The results for interim periods are not necessarily indicative of trends or of results to be expected for the full year.



|2. | BUSINESS
    ACTIVITIES
|-- | -----------------------



On
December 12, 2019, Frontier Oilfield Services, Inc., a Texas Corporation (“FOSI”) entered into a Reorganization and
Stock Purchase Agreement (the “Agreement”) to change its corporate domicile from Texas to Nevada, assume the name
TRICCAR, Inc. (“TRICCAR”), and to acquire 100% of the issued and outstanding equity of TRICCAR Holdings, Inc., a Nevada
Corporation (“TRICCAR Holdings”).



Pursuant
to the Agreement, effective on February 28, 2020, the parties closed the Agreement.



TRICCAR
acquired 100% of the issued and outstanding equity of TRICCAR Holdings, Inc. TRICCAR issued 80,000,000 shares of stock to acquire
all the issued and outstanding equity stock of TRICCAR Holdings while TRICCAR shareholders retained 20,000,000 shares of stock.
As a consequence, immediately subsequent to the acquisition TRICCAR will have approximately 100,000,000 shares of common stock
outstanding. The issuance of the new shares has already been reflected on TRICCAR’s book and is pending the name and symbol
change with transfer agent.



The
accompanying consolidated financial statements include the accounts of the Company and its former entity Frontier Oilfield Services,
Inc., and its subsidiary TRICCAR Holdings, Inc.



TRICCAR
is a vertically integrated biomedical research, development, and marketing firm that plans to develop, acquire, and partner to
bring life-changing bioceutical solutions (not requiring FDA approval) and pharmaceutical drugs (requiring FDA approval) to the
global market. The Company is engaged in the development of bioceutical and pharmaceutical products designed to support the well-being
of humans and animals that have common diseases.



Development
Stage Company – The Company is considered a development stage company and has had no commercial revenue to date. The Company
has been focusing on the development of its products.



|3. | GOING
    CONCERN
|-- | -----------------



The
Company’s financial statements are prepared using U.S. generally accepted accounting principles (“U.S. GAAP”)
applicable to a going concern which contemplates the realization of assets and liquidation of liabilities in the normal course
of business. As of the date of the financial statements, the Company has generated losses from operations, has an accumulated
deficit and working capital deficiency. These factors raise substantial doubt regarding the Company’s ability to continue
as a going concern.



To
continue as a going concern and achieve a profitable level of operations, the Company will need, among other things, to increase
its business volume and grow revenues, reduce its operating expenses, raise additional capital resources and develop new and stable
sources of revenue to meet its operating expenses.



The
Company’s ability to continue as a going concern will be dependent upon management’s ability to successfully implement
management’s plans to pursue additional business volumes from new and existing customers, reduce indebtedness through sales
of non-performing assets and conversions of debt to equity, and rationalize the Company’s cost structure to achieve profitable
operations. The accompanying financial statements do not include any adjustments that might be necessary if the Company is unable
to continue as a going concern. The Company’s continued existence will ultimately be dependent on its ability to generate
cash flows to support its operations as well as provide sufficient resources to retire existing liabilities on a timely basis.
The Company faces significant risk in implementing its business plan and there can be no assurance that financing for its operations
and business plan will be available or, if available, such financing will be on satisfactory terms.





7









|4. | SUMMARY
    OF SELECTED ACCOUNTING POLICIES
|-- | -------------------------------------------



Reverse
Merger

The
Share Exchange closed on February 28, 2020. As a result of the Share Exchange, the former shareholders of TRICCAR Holdings became
the controlling shareholders of the Company. At the closing, each TRICCAR Holdings shareholder received 1.00 shares (the “Exchange
Ratio”) of TRICCAR Inc. common stock for each TRICCAR Holdings share exchanged. The Share Exchange was accounted for as
a reverse takeover/recapitalization effected by a share exchange, wherein TRICCAR Holdings is considered the acquirer for accounting
and financial reporting purposes. The capital, share price, and earnings per share amount in these consolidated financial statements
for the period prior to the reverse merger were restated to reflect the recapitalization in accordance with the exchange ratio
established in the merger except otherwise noted.



TRICCAR
Holdings, incorporated on August 22, 2017, is a vertically integrated biomedical research, development, and marketing firm that
develops, acquires, and partners to bring life-changing bioceutical solutions (not requiring FDA approval) and pharmaceutical
drugs (requiring FDA approval) to the global market. The Company is engaged in the development of bioceutical and pharmaceutical
products designed to support the well-being of humans and animals that have common diseases.



As
a result of the Merger, TRICCAR Holdings stock owned by the Company has been cancelled and each share of TRICCAR Holdings not
owned by the Company was exchanged for 1.00 share of Company’s common stock. A total of 80,000,000 shares of TRICCAR Holdings
common stock was exchanged for 80,000,000 shares of Company common stock.



Principles
of Consolidation

The
consolidated financial statements include the accounts of the Company and its wholly-owned subsidiaries. All significant inter-company
transactions and balances have been eliminated in consolidation.



Fair
Value of Financial Instruments

In
accordance with the reporting requirements of ASC Topic 825, Financial Instruments, the Company calculates the fair value
of its assets and liabilities which qualify as financial instruments under this standard and includes this additional information
in the notes to the financial statements when the fair value is different than the carrying value of those financial instruments.
The Company does not have assets or liabilities measured at fair value on a recurring basis. Consequently, the Company did not
have any fair value adjustments for assets and liabilities measured at fair value at the balance sheet dates, nor gains or losses
reported in the statements of operations that are attributable to the change in unrealized gains or losses relating to those assets
and liabilities still held during the three months ended March 31, 2020 and 2019, except as disclosed.



Earnings
(Loss) Per Share (EPS)

Basic
earnings per common share are calculated by dividing net income or loss by the weighted average number of shares outstanding during
the period. Diluted earnings per common share are calculated by adjusting outstanding shares, assuming conversion of all potentially
dilutive stock options and warrants. The computation of diluted EPS does not assume conversion, exercise, or contingent issuance
of shares that would have an anti-dilutive effect on earnings per common share. Anti-dilution results from an increase in earnings
per share or reduction in loss per share from the inclusion of potentially dilutive shares in EPS calculations. Currently there
are no common stock dilutive instruments in 2020 or 2019 which have been excluded from EPS that could potentially have a dilutive
effect on EPS in the future.



Use
of Estimates

The
preparation of the unaudited consolidated financial statements in conformity with accounting principles generally accepted in
the U.S. requires management to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues,
expenses, and the related disclosures at the date of the financial statements and during the reporting period. Actual results
could materially differ from these estimates. Significant estimates in the three months ended March 31, 2020 and 2019 include
the allowance for doubtful accounts on accounts and other receivables, the useful life of property and equipment and intangible
assets, and assumptions used in assessing impairment of long-term assets.



Revenue
Recognition

The
Company recognizes revenues when services are rendered, products are delivered, and when payment is determinable and reasonably
assured. The Company plans to extend short-term, unsecured credit to its distributors for amounts invoiced.





8









|5. | COMMITMENTS
    AND CONTINGENCIES
|-- | ---------------------------------



The
COVID-19 pandemic

In
December 2019, when the first indications of SARS-CoV-2 were being reported from Wuhan, China, Management began implementing plans
to incorporate work-from-home initiatives, acquiring face masks and gloves for employees, and accumulating disinfectants such
as alcohol and bleach. On January 27, 2020 the Company formally put in place work-from-home efforts. On March 12, 2020, Nevada
Governor Steve Sisolak implemented state-at-home orders for businesses and employees which are still in effect. While our early
identification of the risks of SARS-CoV-2 have protected our employees with zero cases of COVID-19 infection to date, the global
pandemic has delayed the Company’s plans to bring 11 of our products to market due to supplier and transportation limitations.
Given the continued challenges of the pandemic, Management is unable to provide a definitive date when our first bioceutical products
will be made available for public purchase. The pandemic has resulted in record unemployment in the United States which impacts
consumers’ financial ability to purchase bioceuticals and this retraction in employment and consumer confidence may have
a negative short-term impact on the Company.



|6. | EQUITY                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           
|-- | ---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|   | The
        total number of common stock authorized that may be issued by the Company is four hundred million (400,000,000) shares
        of common stock with a par value of one hundredth of one cent ($0.0001) per share consisting of three hundred seventy-two
        million five hundred thousand (372,500,000) shares Class A shares with 1:1 voting rights and twenty-seven million five
        hundred thousand (27,500,000) Class B shares with 20:1 voting rights, and fifty million (50,000,000) shares of preferred
        stock with a par value of one hundredth of a cent ($0.0001) per share. To the fullest extent permitted by the laws of
        the state of Nevada (currently set forth in NRS 78.195), as the same now exists or may hereafter be amended or supplemented,
        the board of directors may fix and determine the designations, rights, preferences or other variations of each class or
        series within each class of capital stock of the corporation.
        
        There
        are currently 72,500,000 shares of Common stock- Class A and 27,500,000 shares of Common stock- Class B outstanding pending
        issuance with name and symbol change. The Class B common stock includes 20,000,000 shares held by William Townsend, Chief
        Executive Officer and Director and 7,500,000 shares held by Katrina Yao, Chief Financial Officer and director.
|7. | RELATED
        PARTY TRANSACTIONS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               
|   | None                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  
|8. | SUBSEQUENT
        EVENTS                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        
|   | The
    Company has completed an agreement for an investment of $18,594,692 via private placement in the public entity from Antonomastic
    Investment Holdings, Ltd., resulting in the sale of 11,621,683 shares of common stock at $1.60 per share. As part of the investment,
    Nairobi, Kenya based Antonomastic Investment Holdings, Ltd. will appoint a yet to be determined member to TRICCAR’s
    board of directors. As of the date of this report, no funds have been received by TRICCAR, Inc.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    
|   |                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  

ITEM
2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS



CAUTIONARY
STATEMENT



Statements
in this report which are not purely historical facts, including statements regarding the Company’s anticipations, beliefs,
expectations, hopes, intentions or strategies for the future, may be forward-looking statements within the meaning of Section
21E of the Securities Act of 1934, as amended. All forward-looking statements in this report are based upon information available
to us on the date of the report. Any forward-looking statements involve risks and uncertainties that could cause actual results
or events to differ materially from events or results described in the forward-looking statements. Important factors with respect
to any such forward-looking statements, including certain risks and uncertainties that could cause actual results to differ materially
from the Company’s expectations (“Cautionary Statements”), are disclosed in the Company’s annual report
on Form 10-K, including, without limitation, in conjunction with the forward-looking statements under the caption “Risk
Factors.” In addition, important factors that could cause actual results to differ materially from those in the forward-looking
statements included herein include, but are not limited to, limited working capital, limited access to capital, changes from anticipated
levels of sales and revenues changes in the oil and gas markets especially in the oil field services markets and fluids disposal
business, future national or regional economic and competitive conditions, changes in relationships with customers, difficulties
in developing new business in the disposal business, difficulties integrating any new businesses or products acquired, replacing
the lost customer revenue, regulatory change, the ability of the Company to meet its stated business goals, the Company’s
restructuring initiatives, the Company’s ability to sustain profitability, the Company’s ability to service its debt,
its ability to comply with covenants contained in its financing arrangements, the current defaults existing under the Company’s
senior and subordinated credit arrangements, and general economic and business conditions. Although the Company believes the expectations
reflected in such forward-looking statements are reasonable, it can give no assurance that such expectations will prove to have
been correct. All subsequent written and oral forward-looking statements attributable to the Company or persons acting on its
behalf are expressly qualified in their entirety by the Cautionary Statements. We do not undertake to update any forward-looking
statements. Readers are cautioned not to place undue reliance on these forward-looking statements.



9







As
a result of the Reorganization Agreement and the change in business and operations of the Company, a discussion of the past financial
results of the Company, formally known as Frontier Oilfield Services, Inc., is not pertinent, and, under generally accepted accounting
principles in the United States the historical financial results of TRICCAR Holdings, Inc., the acquired company for accounting
purposes, prior to the Reorganization Agreement are considered the historical financial results of the Company.



The
following discussion highlights the Company’s results of operations and the principal factors that have affected its consolidated
financial condition as well as its liquidity and capital resources for the periods described, and provides information that management
believes is relevant for an assessment and understanding of the Company’s consolidated financial condition and results of
operations presented herein. The following discussion and analysis are based on the Company’s unaudited financial statements
contained in this Current Report, which have been prepared in accordance with generally accepted accounting principles in the
United States. You should read the discussion and analysis together with such financial statements and the related notes thereto.



OVERVIEW



TRICCAR
Inc. (or “TRICCAR” or “the Company”) is a public Nevada C-corporation and vertically integrated biomedical
research, development, and marketing firm that develops, acquires, and partners to bring bioceutical solutions (not requiring
FDA approval) and pharmaceutical drugs (requiring FDA approval) to the global market.



The
Company is engaged in the development of bioceutical and pharmaceutical products designed to support the well-being of humans
and animals that have ailments and diseases. The Company’s dual-approach to product development includes bioceuticals (e.g.,
bioceuticals and over-the-counter products), not requiring FDA approval, and thus being able to enter the market and generate
revenues; along with pharmaceuticals which require FDA approval. It is Management’s intent to pursue strategic partnerships
with larger pharmaceutical companies to underwrite the costs of FDA approval as needed. This approach minimizes risks for the
Company by providing revenue streams from our first eighteen (18) nutraceutical products planned for introduction between September
2020 and August 2022, and thus, generate revenue while we concurrently pursue our partnership approach to FDA approval of our
pharmaceuticals, which Management intends to do beginning with a possible cure for ALS (Lou Gehrig’s disease).



The
Company’s products includes bioceutical formulations designed to support 38 diseases and maladies, including four formulae
centered around the most bioavailable calcium supplement available; a weight loss and obesity supplement that requires no dramatic
change in diet or requirement of exercise; a formula that helps relieve the symptoms of menopause; a fast-acting blood performance
product that separates white and red blood cells; a mental focus formula proven to increase attention and recall of information
and beneficial to children diagnosed with Attention Deficit Disorder (“ADHD”); a mental acuity formula proven to increase
memory recall and aid in the formation of new memories; and others.



SIGNIFICANT
ACCOUNTING POLICIES



The
preparation of financial statements in conformity with US Generally Accepted Accounting Principles requires management to make
estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities
at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual
results may differ from those estimates. The Company has adopted ASC 842 requiring the recoding of assets and liabilities related
to leases on the balance sheet. The Company records rent on straight-line basis over the terms of the underlying leases.





10









RESULTS
OF OPERATIONS



For
the three months ended March 31, 2020, we reported a net loss of $27,620 as compared to a net loss of $287,363 for the three months
ended March 31, 2019. The components of these results are explained below.



Revenue- No revenue was generated for the three months ended March 31, 2020.



Expenses
- The components of our costs and expenses for the three months ended March 31, 2020 and 2019 are as follows:



|                            |  | For
    the Three Months Ended |        |  | %             |  
|--------------------------- |  | ------------------------------ | ------ |  | ------------- | -
|                            |  | March
    31,                  |        |  | March
    31, |  
|                            |  | 2020                           |        |  | 2019          |  
|Costs
    and expenses:     |  |                                |        |  |               |  
|General and administrative  |  |                                | 27,620 |  |               |  
|                            |  |                                |        |  |               |  
|Total cost and
    expenses |  | $                              | 27,620 |  |               | $



Operating
results for the three months ended March 31, 2020 and 2019 reflect a net loss of $27,620 and a net loss of $16,871 respectively.
We have not recorded any federal income taxes for the three months ended March 31, 2020 and 2019 because of our accumulated losses
and our net operating loss carry forwards.



LIQUIDITY
AND CAPITAL RESOURCES



Cash
Flows and Liquidity



As
of March 31, 2020, we had total current assets of $20,261. Our total current liabilities as of March 31, 2020 were approximately
$217,241. We had a working capital deficit of approximately $196,980 as of March 31, 2020.



Management
are seeking to raise up to $15,000,000 through PIPE financing, which we will use for operations and growth.



As
of March 31, 2020, we had $20,261 in cash, a decrease of $9,206 from December 31, 2019 due to minimal general administrative expenses.



Capital
Expenditures



The
Company suspended capital expenditures during the three months ended March 31, 2020 due to low working capital available.



Outlook



Management
are seeking to raise up to $15,000,000 through PIPE financing, which we will use for operations and growth. However, if in the
future we do not turn profitable or generate cash from operations and additional capital is needed to support operations, economic
and market conditions may make it difficult or impossible to raise additional funds through debt or equity financings. If funds
are not sufficient to support operations, we may need to pursue a financing or reduce expenditures to meet our cash requirements.
If we do obtain such financing, we cannot assure that the amount or the terms of such financing will be as attractive as we may
desire, and your equity interest in the company may be diluted considerably. If we are unable to obtain such financing when needed,
or if the amount of such financing is not sufficient, it may be necessary for us to take significant cost saving measures or generate
funding in ways that may negatively affect our business in the future. To reduce expenses, we may be forced to make personnel
reductions or curtail or discontinue development programs. To generate funds, it may be necessary to monetize future royalty streams,
sell intellectual property, divest of technology platforms or liquidate assets. However, there is no assurance that, if required,
we will be able to generate sufficient funds or reduce spending to provide the required liquidity. Long term capital requirements
will depend on numerous factors, including, but not limited to, the status of collaborative arrangements, the progress of research
and development programs and the receipt of revenues from sales of products.





11







ITEM
3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK



Not
required for smaller reporting companies.



ITEM
4. CONTROLS AND PROCEDURES



Disclosure
Controls and Procedures

Our
management evaluated, with the participation of our Chief Executive Officer (CEO) and Chief Financial Officer (CFO), the effectiveness
of the design and operation of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities
Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the quarter covered by this quarterly report
on Form 10-Q. In making this assessment, the Company used the criteria set forth by the Committee of Sponsoring Organizations
of the Treadway Commission (COSO) in Internal Control-Integrated Framework .



A
material weakness is a deficiency or combination of deficiencies in internal control over financial reporting, such that there
is a reasonable possibility that a material misstatement of the annual or interim financial statements will not be prevented or
detected on a timely basis by the Company’s internal controls.



The
Company’s management has identified a material weakness in the effectiveness of internal control over financial reporting
related to a shortage of resources in the accounting department required to assure appropriate segregation of duties with employees
having appropriate accounting qualifications related to the Company’s unique industry accounting and disclosure rules. Management
has outsourced certain financial functions to mitigate the material weakness in internal control over financial reporting. The
Company is reviewing its finance and accounting staffing requirements.



Internal
Control Over Financial Reporting

There
have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f)
and 15d-15(f) under the Exchange Act) during the fiscal quarter to which this report relates that have materially affected, or
are reasonably likely to materially affect, the Company’s internal control over financial reporting. As a result, no corrective
actions were required or undertaken.



Limitations
on the Effectiveness of Controls

Our
management, including the CEO, does not expect that its disclosure controls or its internal controls will prevent all errors and
all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that
the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource
constraints, and the benefits of controls must be considered relative to their costs. Because of the inherent limitations in all
control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any,
within the company have been detected. These inherent limitations include the realities that judgments in decision-making can
be faulty, and that breakdowns can occur because of simple errors or mistakes. Additionally, controls can be circumvented by the
individual acts of some persons, by collusion of two or more people, or by management override of the control. The design of any
system of controls also is based in part upon certain assumptions about the likelihood of future events, and there can be no assurance
that any design will succeed in achieving its stated goals under all potential future conditions; over time, control may become
inadequate because of changes in conditions, or the degree of compliance with the policies or procedures may deteriorate. Because
of the inherent limitations in a cost-effective control system, misstatements due to error or fraud may occur and not be detected.



PART
II. OTHER INFORMATION



Item
1. LEGAL PROCEEDINGS



None.



Item
2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS



None.



Item
3. DEFAULTS UPON SENIOR SECURITIES



None





12







Item
5. OTHER INFORMATION



This
is to add this additional disclosure of the Company’s reliance on the March 4, 2020 order issued by the Commission under
Section 36 (Release No. 34-88318), as modified on March 25, 2020 (Release No. 34-88465) of the Securities Exchange Act of 1934
(“Exchange Act”) granting exemptions from specified provisions of the Exchange Act and certain rules thereunder (the
“Order”), as a result of the novel coronavirus (“COVID-19”) pandemic, to file the Company’s Original
10-Q when originally due on May 15, 2020.



The
Company was not able to file its Original 10-Q by the original due date as a result of disruptions caused by the COVID-19 pandemic.
The COVID-19 pandemic has impacted the Company through inaccessibility to key partners and their services. A significant portion
of the Company’s business operations are contracted in certain domestic markets currently on “lock-down” orders
or “shelter in place” recommendations for the national health crisis, including key personnel responsible for assisting
the Company in the development of its financial statements. As a result of the travel and work restrictions stemming from the
COVID-19 pandemic, the Company was unable to obtain financial records that it needs from its operations to permit the Company
to file a timely and accurate Quarterly Report on Form 10-Q for its quarter ended March 31, 2020 by the prescribed date without
undue hardship and expense to the Company.



Item
6. EXHIBITS



| | (a) | EXHIBITS:
| | --- | ---------
| |     |          

| |     | 31.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
| | --- | -------------------------------------------------------------------------------------------------------------------------------------------------------
| |     |                                                                                                                                                        
| |     | 31.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
| |     |                                                                                                                                                        
| |     | 32.1 Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
| |     |                                                                                                                                                        
| |     | 32.2 Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
| |     |                                                                                                                                                        
| | 101 | 101.INS XBRL Instance
    Document                                                                                                                     
| |     |                                                                                                                                                        
| |     | 101.SCH XBRL Taxonomy
    Schema                                                                                                                       
| |     |                                                                                                                                                        
| |     | 101.CAL XBRL Taxonomy
    Calculation Linkbase                                                                                                         
| |     |                                                                                                                                                        
| |     | 101.LAB XBRL Taxonomy
    Label Linkbase                                                                                                               
| |     |                                                                                                                                                        
| |     | 101.PRE XBRL Taxonomy
    Presentation Linkbase                                                                                                        
| |     |                                                                                                                                                        
| |     | 101.DEF XBRL Taxonomy
    Definition Linkbase                                                                                                          





SIGNATURES



In
accordance with Section 13 or 15(d) of the Exchange Act, the registrant has caused this report to be signed on its behalf by the
undersigned, thereunto duly authorized, on July 21, 2020.



TRICCAR,
INC.



|           |                                                                | 
|---------- | -------------------------------------------------------------- | 
|SIGNATURE: | /s/
    William Townsend                                       | 
|           | William
Townsend,
        Chief
Executive Officer and Director | 



13